Amgen Inc. Modification Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Asset Purchase Agreement between Amgen Inc. and Celgene Corporation
Modification Agreements
Amgen Inc.
Biotechnology
2020
Amendment No. 1 to Asset Purchase Agreement between Celgene Corporation and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2019
Amendment No. 3 to Integrated Facilities Management Services Agreement between Jones Lang LaSalle Americas, Inc. and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2011
First Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective April 11, 2011)
Modification Agreements
Amgen Inc.
Biotechnology
2011
Amendment No. 1 to Expansion Agreement between Glaxo Group Limited and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2010
Amendment to Promissory Note between Richard Nanula and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2007
Amendment to Amended and Restated Rights Agreement between Amgen Inc. and American Stock Transfer & Trust Company (July 11, 2006)
Modification Agreements
Amgen Inc.
Biotechnology
2006
Amendment No. 1 to Amended and Restated Promotion Agreement among Wyeth, Amgen Inc., and Immunex Corporation
Modification Agreements
Amgen Inc.
Biotechnology
2004
Amendment No. 2 to Enbrel Supply Agreement among Genentech, Immunex, and Amgen
Modification Agreements
Amgen Inc.
Biotechnology
2004
Amendment to Offer Letter Between Amgen Inc. and Dr. Beth C. Seidenberg (December 20, 2001)
Modification Agreements
Amgen Inc.
Biotechnology
2002